BIOMERICA INC (BMRA) Gross Margin
- Gross margin · 12 months: Value 8.13%; Formula and calculation Gross profit / revenue. Period ending 2026-05-31..
Gross margin
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 8.13% | Gross profit / revenue. Period ending 2026-05-31. $362.00K ÷ $4.45M × 100 ≈ 8.13% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 362.00K USD | Gross Profit |
| Revenue | 4.45M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-05-31 | $362.00K | $4.45M | (m) | 8.13% |
| 2026-02-28 | $189.00K | $4.33M | (m) | 4.37% |
| 2025-11-30 | $251.00K | $4.46M | (m) | 5.63% |
| 2025-08-31 | $633.00K | $4.88M | (m) | 12.96% |
| 2025-05-31 | $498.00K | $5.31M | (m) | 9.38% |
| 2025-02-28 | $762.00K | $5.68M | (m) | 13.42% |
| 2024-11-30 | $595.00K | $5.58M | (m) | 10.67% |
| 2024-08-31 | $488.00K | $5.51M | (m) | 8.86% |
| 2024-05-31 | $611.00K | $5.42M | (m) | 11.28% |
| 2024-02-29 | $620.00K | $5.41M | (m) | 11.47% |
| 2023-11-30 | $889.00K | $5.50M | (m) | 16.16% |
| 2023-08-31 | $913.00K | $5.42M | (m) | 16.86% |
| 2023-05-31 | $446.00K | $5.34M | (m) | 8.35% |
| 2023-02-28 | $1.04M | $9.53M | (m) | 10.89% |
| 2022-11-30 | $2.59M | $16.08M | (m) | 16.12% |
| 2022-08-31 | $3.01M | $19.25M | (m) | 15.65% |
| 2022-05-31 | $2.98M | $18.87M | (m) | 15.78% |
| 2022-02-28 | $2.37M | $14.62M | (m) | 16.20% |
| 2021-11-30 | $622.27K | $10.59M | (m) | 5.87% |
| 2021-08-31 | $159.23K | $7.32M | (m) | 2.18% |
| 2021-05-31 | $496.98K | $7.20M | (m) | 6.90% |
| 2021-02-28 | $1.24M | $8.87M | (m) | 13.97% |
| 2020-11-30 | $1.49M | $6.42M | (m) | 23.21% |
| 2020-08-31 | $1.60M | $6.64M | (m) | 24.05% |
| 2020-05-31 | $1.78M | $6.69M | (m) | 26.62% |
| 2020-02-29 | $1.23M | $5.13M | (m) | 23.94% |
| 2019-11-30 | $1.38M | $5.22M | (m) | 26.50% |
| 2019-08-31 | $1.32M | $5.12M | (m) | 25.81% |
| 2019-05-31 | $1.29M | $5.20M | (m) | 24.84% |
| 2019-02-28 | $1.38M | $5.17M | (m) | 26.71% |
| 2018-11-30 | $1.48M | $5.28M | (m) | 28.01% |
| 2018-08-31 | $1.58M | $5.39M | (m) | 29.24% |
| 2018-05-31 | $1.75M | $5.56M | (m) | 31.53% |
| 2018-02-28 | $1.92M | $5.88M | (m) | 32.72% |
| 2017-11-30 | $1.91M | $6.01M | (m) | 31.78% |
| 2017-08-31 | $1.96M | $5.83M | (m) | 33.63% |
| 2017-05-31 | $2.02M | $5.79M | (m) | 34.91% |
| 2017-02-28 | $1.93M | $5.67M | (m) | 34.03% |
| 2016-11-30 | $1.82M | $5.53M | (m) | 32.99% |
| 2016-08-31 | $1.68M | $5.26M | (m) | 31.91% |
| 2016-05-31 | $1.52M | $5.14M | (m) | 29.65% |
| 2016-02-29 | $1.64M | $5.31M | (m) | 30.96% |
| 2015-11-30 | $1.76M | $5.25M | (m) | 33.51% |
| 2015-08-31 | $1.65M | $5.21M | (m) | 31.70% |
| 2015-05-31 | $1.54M | $4.96M | (m) | 31.07% |
| 2015-02-28 | $1.65M | $5.15M | (m) | 32.07% |
| 2014-11-30 | $1.77M | $5.34M | (m) | 33.15% |
| 2014-08-31 | $1.72M | $5.14M | (m) | 33.43% |
| 2014-05-31 | $1.67M | $5.12M | (m) | 32.60% |
| 2014-02-28 | $1.58M | $4.91M | (m) | 32.08% |
| 2013-11-30 | $1.44M | $4.84M | (m) | 29.83% |
| 2013-08-31 | $1.96M | $5.78M | (m) | 33.81% |
| 2013-05-31 | $2.43M | $6.47M | (m) | 37.51% |
| 2013-02-28 | $2.49M | (m) | (m) | (m) |
| 2012-11-30 | $2.61M | (m) | (m) | (m) |
| 2012-08-31 | $2.51M | (m) | (m) | (m) |
| 2012-05-31 | $2.30M | (m) | (m) | (m) |
| 2012-02-29 | (m) | (m) | (m) | (m) |
| 2011-11-30 | (m) | (m) | (m) | (m) |
| 2011-08-31 | (m) | (m) | (m) | (m) |
| 2011-05-31 | $1.53M | (m) | (m) | (m) |
| 2011-02-28 | (m) | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |